Stock Financial Ratios

MYOV / Myovant Sciences Ltd. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price14.31
Volume90,000.00
Market Cap ($M)902.64
Enterprise Value ($M)774.29
Book Value ($M)166.78
Book Value / Share2.77
Price / Book10.64
NCAV ($M)165.66
NCAV / Share2.75
Price / NCAV7.95
Income Statement (mra) ($M)
Revenue0.00
EBITDA-83.51
Net Income-83.44
Balance Sheet (mrq) ($M)
Cash & Equivalents0.00
Cash / Share0.00
Assets0.00
Liabilities0.00
Quick Ratio10.04
Current Ratio10.04
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.50
Return on Assets (ROA)
Return on Equity (ROE)
Identifiers and Descriptors
CUSIPG637AM102
Central Index Key (CIK)1679082
Industry Groups
Share Statistics
Common Shares Outstanding60,280,189
Common Stock Shares Outstanding60,275,757
Sharebased Compensation Arrangementby Sharebased Payment Award Options Vested Numberof Shares Outstanding200
Scoring Models
Piotroski F-Score1.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Equity Per Share0.00
Assets Current Per Share0.00
Minority Interest Per Share0.00
Inventory Work In Progress Per Share0.00
Additional Paid In Capital Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Cash Per Share0.00
Accounts Payable Per Share0.00
Debt Per Share0.00
Inventory Per Share0.00
Retained Earnings Per Share0.00
Liabilities And Stock Equity Per Share0.00
Assets Other Non Current Per Share0.00
Intangibles Per Share0.00
Goodwill Per Share0.00
Property Plant And Equipment Net Per Share0.00
Liabilities Current Per Share0.00
Assets Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00
Property Plant And Equipment Per Share0.00
Inventory Raw Materials Per Share0.00
Liabilities Per Share0.00
Cash And Equivalents Per Share0.00
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00

Peers -

Related News Stories

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2017 Update

2018-02-22 seekingalpha
Halvorsen's 13F portfolio value increased from $15.44B to $16.26B. The number of positions remained steady at 59. (1180-3)

Another Phase III Win For Neurocrine Biosciences

2018-02-22 seekingalpha
AbbVie announced that elagolix met its primary and secondary efficacy endpoints in the first of two Phase III studies for uterine fibroids. (163-1)

OBSEVA: Obstetrics And Women's Health

2018-02-05 seekingalpha
ObsEva is one of those small cap clinical-stage biotechs, somewhat de-risked, with multiple shots on goal and potential for re-valuation that biotech investors love. (96-0)

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2017 Update

2017-11-21 seekingalpha
Halvorsen's 13F portfolio value increased from $14.85B to $15.44B. The number of positions increased from 53 to 59. (1331-7)

BRIEF-Myovant Sciences secures flexible financing commitments

2017-10-16 reuters
* Myovant Sciences-‍under terms of agreement with Novaquest, co can request note purchases of up to $60 million at Myovant’s discretion through dec 31, 2018​ (14-0)

CUSIP: G637AM102